Diffuse multicystic encephalomalacia in a preterm baby due to homozygous methylenetetrahydrofolate reductase 677 C-->T mutation

J Child Neurol. 2008 Jun;23(6):695-8. doi: 10.1177/0883073807312371.

Abstract

Methylenetetrahydrofolate reductase catalyzes the formation of 5-methyltetrahydrofolate from 5,10-methylentetrahydrofolate and produces folate for the methylation of homocysteine to methionine. Due to insufficient conversion of homocysteine to methionine, plasma homocysteine levels increase in methylenetetrahydrofolate reductase deficiency. Homocysteine is an amino acid that contains a neurotoxic sulfur molecule and can induce neuronal apoptosis. Methylenetetrahydrofolate reductase deficiency is 1 of the etiological factors that causes neurological symptoms and signs in the newborn and childhood period. Here, we report a premature baby with prenatal onset diffuse multicystic encephalomalacia and cerebellar atrophy due to homozygous methylenetetrahydrofolate reductase mutation.

Publication types

  • Case Reports

MeSH terms

  • Brain / pathology
  • Cerebral Hemorrhage / genetics
  • Cerebral Hemorrhage / pathology
  • DNA Mutational Analysis*
  • Echoencephalography
  • Encephalomalacia / diagnosis
  • Encephalomalacia / genetics*
  • Humans
  • Infant, Newborn
  • Infant, Premature, Diseases / diagnosis
  • Infant, Premature, Diseases / genetics*
  • Magnetic Resonance Imaging
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / deficiency
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Myoclonic Cerebellar Dyssynergia / diagnosis
  • Myoclonic Cerebellar Dyssynergia / genetics*
  • Tomography, X-Ray Computed

Substances

  • Methylenetetrahydrofolate Reductase (NADPH2)